SriKrishna Pharmaceuticals Ltd
SriKrishna Pharmaceuticals Ltd., headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of a diverse range of pharmaceutical products. Founded in 1993, the company has established a strong presence in key operational regions, focusing on both domestic and international markets. With a commitment to quality and innovation, SriKrishna Pharmaceuticals offers a variety of formulations, including generic and branded medications, catering to various therapeutic segments. The company is recognised for its state-of-the-art manufacturing facilities and adherence to stringent regulatory standards, which set it apart in a competitive landscape. Over the years, SriKrishna Pharmaceuticals has achieved significant milestones, positioning itself as a trusted name in the industry. Its dedication to research and development, coupled with a robust product portfolio, underscores its reputation as a leader in the pharmaceutical sector.
DitchCarbon Score
How does SriKrishna Pharmaceuticals Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SriKrishna Pharmaceuticals Ltd's score of 4 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SriKrishna Pharmaceuticals Ltd's reported carbon emissions
SriKrishna Pharmaceuticals Ltd, headquartered in India, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. As such, SriKrishna Pharmaceuticals Ltd may benefit from establishing clear emissions reduction targets and engaging in industry-standard climate initiatives to enhance its sustainability profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SriKrishna Pharmaceuticals Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
